Oral Administration of β-Glucosylceramide for the Treatment of Insulin Resistance and Nonalcoholic Steatohepatitis: Results of a Double-Blind, Placebo-Controlled Trial-Reference-Cited by-同舟云学术

Oral Administration of β-Glucosylceramide for the Treatment of Insulin Resistance and Nonalcoholic Steatohepatitis: Results of a Double-Blind, Placebo-Controlled Trial

Published:2017-05 Issue:5 Volume:20 Page:458-464
ISSN:1096-620X
Container-title:Journal of Medicinal Food
language:en
Short-container-title:Journal of Medicinal Food

Author:

Lalazar Gadi¹,Zigmond Ehud¹,Weksler-Zangen Sarah²,Ya'acov Ami Ben¹,Levy Miriam Sklair³,Hemed Nilla¹,Raz Itamar²,Ilan Yaron¹

Affiliation:

1. Gasroeterology and Liver Units, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

2. Diabetes Unit, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

3. Department of Radiology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Publisher

Mary Ann Liebert Inc

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://www.liebertpub.com/doi/pdf/10.1089/jmf.2016.3753

Reference55 articles.

1. Epidemiology and Natural History of NAFLD and NASH

2. Non-alcoholic fatty liver disease and the metabolic syndrome: An update

3. Review article: diagnosis and treatment of non-alcoholic fatty liver disease

4. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

5. Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Dose Colchicine Attenuates Sepsis-Induced Liver Injury: A Novel Method for Alleviating Systemic Inflammation;Inflammation;2023-01-19

2. Decoding the role of immune T cells: A new territory for improvement of metabolic‐associated fatty liver disease;iMeta;2023-01-18

3. Increased hepatic Akt phosphorylation alleviated glucose intolerance and improved liver function in leptin-deficient mice;Clinical and Experimental Hepatology;2023

4. Serum sphingolipid profiling as a novel biomarker for metabolic syndrome characterization;Frontiers in Cardiovascular Medicine;2022-12-12

5. New insights into iNKT cells and their roles in liver diseases;Frontiers in Immunology;2022-10-26